2004

Van Eyk JE. Clinical Proteomics ? application to cardiovascular pulmonary disease NIH Proteomic Seminar Series, Bethesda MD. March 2004.
 

Van Eyk JE. Proteomics in heart disease: mechanism to biomarkers. Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI March, 2004.
 

Van Eyk JE. Broad based Proteomic Analysis in Heart disease. Experimental Biology Meeting, Washington, DC, April 2004.
 

Van Eyk JE. Proteomics applied to heart disease ? math to biomarkers. IPAM, Los Angeles, CA April, 2004.
 

Van Eyk JE. Proteomics in Heart disease: mechanism to clinical biomarkers. Department of Physiology, ULCA, Los Angeles, CA April, 2004.
 

Van Eyk JE. Cardiovascular proteomics provide insight in to heart failure. Aging heart and vessels (submeeting of ISHR) Melbourne, Australia, Aug., 2004.
 

Van Eyk JE. Disease staging and risk stratification biomarkers: disease induced protein modifications. Protein Biomarkers 2004, Cambridge Healthtech Institute, Philadelphia. PA Sept 2004
 

Van Eyk JE. Heart disease: mechanism to biomarkers. Federation of Analytical Chemists and Spectroscopy Societies, Portland, OR, Oct. 2004.
 

Murphy AM. Repetitive Stunning, Hibernation and the Contractile Proteins Anne M Murphy, Cardiovascular Seminar. American Heart Association Meeting, New Orleans, CA., Nov. 2004.
 

Zachara NE, Jones SP, Marban E, Hart GW. Increased O-GlcNAc in response to stress, a survival response of mammals. Glycobiology Society, Honolulu, Hawaii, 2004.
 

Zachara NE, Hart GW. O-GlcNAc a mediator of cellular function: characterizing a family of O-GlcNAc binding proteins. Glycobiology Society, Honolulu, Hawaii 2004.
 

Crawford GL, Hart GW, Whiteheart SW. Role of O-GlcNAc in Platelet Activation and Function. American Heart Association Meeting, Nov. 2004.
 

Jones SP, Zachara NE, Leppo MK, Hart GW, Marbán E. Ischemic Preconditioning Augments Novel Glycosyl Post-translational Modification Sufficient for Cardioprotection. American Heart Association Meeting, Nov. 2004.
 

Jones SP, Zachara NE, Teshima Y, Hart GW, Marban E. Intracellular metabolic switch imparts cardioprotective effects and may represent a novel mechanism of ischemic preconditioning. Experimental Biology, April, 2004.
 

Zachara NE, O'Donnell N, Mercer JJ, Marth JD, Hart GW. Nucleocytoplasmic Glycosylation, O-linked ?-N-acetylglucosamine, a Sensor of Cellular Stress. American Society for Biochemistry & Molecular Biology. 2004.
 

Zachara NE, Butkinaree C, Hart GW. O-GlcNAc: A New Paradigm for Modulating Cellular Responses to Stress. Society for Glycobiology. 2004.
 

Hart GW, Zachara NE, Wells L, Vosseller K, Iyer S, Kamemura K, Sakabe K, Cheung W, Slawson C, Whelan S, Lakshmanan T. Dynamic Protein Glycosylation by O-GlcNAc is a Metabolic Sensor Modulating Transcription, Signaling and Stress Responses in all Multi-C
 

Hart GW, Zachara NE, Jones SP, Teshima Y, Marban E. O-GlcNAcylation Globally Protects Cells from Stress and is Cardioprotective. Invited Speaker: 'Oxidative Post-Translational Modifications in the Cardiovascular System,' Boston University School of Medic
 

2003

McDonough JL, Marbán E. Mitochondrial Subfractionation and Analysis of Basic Proteins in Cardiac Myocytes. International Council of Electrophoresis Societies Meeting in Glasgow, UK, May 27-30 2003.
 

Hart G. Dynamic Interplay Between O-GlcNAc and Phosphorylation: Roles in Signaling, Stress Responses and Transcription. FEBS International Meeting on Signal Transduction, Plenary Lecture, Brussels, Belgium, 2003.
 

Hart G. O-Linked N-Acetylglucoamine (O-GlcNAc) is a Metabolic Sensor Modulating Transcription, Signaling and Stress Responses. Thirteenth Annual Beckman Symposium, City of Hope, Duarte, CA, 2003.
 

Hart G. Dynamic Interplay Between O-GlcNAc and Phosphorylation: Roles in Signaling, Stress Responses, and Transcription. Annual Meeting of the American Chemical Society, New York, NY, 2003.
 

Cotter RJ, Gardner BD, Iltchenko S, English RD. Tandem Time-of-Flight Mass Spectrometry with a Curved Field Reflectron, American Society for Mass Spectrometry in Montreal, June 2003.
 

Iltchenko S, Gardner BD, English RD, Cotter RJ. Tandem TOF/TOF Mass Spectrometry at Very High (20 keV) Collision Energies, American Society for Mass Spectrometry in Montreal, June 2003.
 

Colantonio DA,Van Eyk JE. Removal of Albumin and Immunoglobulin from Serum Facilitates Proteomic Analysis. HUPO meeting, October 2003.
 

Hesketh GG, McDonald TG, Brown HA, Van Eyk JE. Purification of cardiac sarcoplasmic reticulum vesicles by affinity chromatography and separation of the ryanodine receptor by SDS-agarose gel electrophoresis. International Council of Electrophoresis Societ
 

Van Eyk JE. Troponin I and new serum biomarkers. 7th Joint Summit on markers of cardiology, Louisville, KY. Oct. 2003
 

Van Eyk JE. New markers of candidate proteins in acute coronary disease ? risk stratification and early detection of ischemic injury. Cardiovascular seminar, American Heart Association Annual Meeting. Nov. 2003
 

Pandey A. Translational Cancer Research: From Basic Science to Patient Care. Mass Spectrometry-based Proteomics for a Global Analysis of Signal Transduction Pathways. Vermont Cancer Center Research Symposium Burlington, VT, October, 2003.
 

Pandey A. Bioinformatics issues with database searching with genomic and proteomic data. Michigan Bioinformatics Seminar Series, University of Michigan, Ann Arbor, Michigan. October, 2003,
 

Pandey A. Proteomic Approaches for Studying Signal Transduction Pathways. 4th Workshop on Molecular Medicine, Madrid, Spain, November, 2003.
 

Pandey A. Proteomic Approaches for Phosphorylation Analysis. Division of Gastroenterology, Johns Hopkins University, Baltimore, MD. December, 2003.
 

Pandey A. Proteomic Approaches to Study Signal Transduction Pathways. Vanderbilt Cancer Center Seminar Series, Nashville, TN. December, 2003,